Introduction: Tumor lysis syndrome is a critical oncologic emergency most commonly associated with hematologic malignancies. However, it can also occur in patients with solid tumors, especially following systemic cytotoxic chemotherapy. Prompt identification and management are essential, as this syndrome can rapidly lead to severe metabolic disturbances, acute kidney injury, and multiorgan failure. Case Presentation: We describe a 65-year-old woman with a history of metastatic uterine leiomyosarcoma who presented to the emergency department with progressive weakness, lightheadedness, and hypotension, six days after receiving a cycle of doxorubicin and trabectedin with concurrent pelvic radiation. Initial evaluation revealed tachycardia, hypotension, pancytopenia, elevated lactate, rising creatinine, and electrolyte abnormalities including hyperkalemia and hyperuricemia. Imaging identified a necrotic pelvic mass and bilateral hydronephrosis. Tumor lysis syndrome was diagnosed and treated with intravenous fluids, rasburicase, and electrolyte correction. Despite initial efforts, the patient developed worsening kidney function, requiring urgent hemodialysis and admission to the intensive care unit. Her clinical course was further complicated by vasopressor-dependent shock, and ongoing tumor necrosis. Nephrology, oncology, critical care, surgery, and palliative care teams were engaged throughout her hospitalization to provide coordinated management and support. Conclusion: This case illustrates the potential for tumor lysis syndrome to occur in solid tumors following chemotherapy and the vital role of emergency physicians in early recognition and initiation of treatment. Multidisciplinary care and early involvement of palliative services are essential in managing these complex, high-acuity cases and ensuring patient-centered outcomes.
Acute kidney injury in pregnancy is associated with increased risks for adverse maternal and neonatal outcomes: an integrated health system study
Abstract Background Pregnancy-related acute kidney injury (PrAKI) is an uncommon but serious complication associated with adverse maternal and neonatal outcomes, with limited data in high-resource settings. Methods We conducted a retrospective cohort study of 29 586 deliveries at Mayo Clinic hospitals between 2017 and 2022. PrAKI was defined using Kidney Disease Improving Global Outcomes (KDIGO) creatinine criteria. Maternal characteristics, nephrotoxin exposure, clinical interventions, and neonatal outcomes were compared between patients with and without PrAKI. Results PrAKI occurred in 341 patients (1.15%). Compared with controls, PrAKI was associated with higher rates of chronic hypertension (28.7% vs 5.2%), cesarean delivery (68.5% vs 35.1%), intensive care unit (ICU) admission (59.1% vs 6.2%), and nephrotoxin exposure (58.7% vs 31.6%) (all P < .0001). Dialysis was required in 7.1% of patients with PrAKI, with 1.17% remaining dependent at discharge and 0.88% at 30 and 90 days; no control patients required dialysis. Neonates of mothers with PrAKI had higher rates of prematurity and neonatal ICU (NICU) admission (48.7% vs 9.8%; P < .0001). Maternal mortality was rare. Conclusions PrAKI is a marker of severe maternal illness and is associated with adverse maternal and neonatal outcomes. Although most patients recover kidney function, a subset develop persistent dysfunction. Early identification, cautious use of nephrotoxic medications, and structured postpartum follow-up are essential.
1430: SYSTEMIC THROMBOLYSIS VS CATHETER-DIRECTED INTERVENTION FOR PULMONARY EMBOLISM: A MULTI-CENTER STUDY
Acute Intracerebral Hemorrhage Associated with Extensive Venous Thrombosis Due to Spontaneous Heparin-Induced Thrombocytopenia After Total Knee Replacement: A Case Report
Introduction: Heparin-induced thrombocytopenia (HIT) is an autoimmune life-threatening prothrombotic syndrome associated with low platelet count after heparin exposure. Spontaneous heparin-induced thrombocytopenia (S-HIT) is an even less frequent variant of HIT, with only a handful of reports available in the literature, where unexplained thrombocytopenia and/or thrombosis without recent heparin exposure occurs in the setting of positive anti-PF4 antibodies. Case Presentation: We report a case of S-HIT associated with pulmonary artery embolism, left internal jugular vein, and cerebral vein sinus thrombosis complicated with ipsilateral acute intracerebral hemorrhage. Discussion: It is important to highlight that in patients with otherwise unexplained thrombocytopenia and prior exposure to an inflammatory process, S-HIT should be on the differential. Conclusions: Recognition and avoidance of heparin exposure is the most important aspect of S-HIT, as the management is otherwise similar to HIT.